SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-11-001329
Filing Date
2011-11-21
Accepted
2011-11-21 20:36:56
Documents
1
Period of Report
2011-11-18

Document Format Files

Seq Description Document Type Size
1 form4-11212011_051147.html 4  
1 form4-11212011_051147.xml 4 3069
  Complete submission text file 0001415889-11-001329.txt   4543
Mailing Address 500 BOYLSTON STREET SUITE 1600 BOSTON MA 02116
Business Address 500 BOYLSTON STREET SUITE 1600 BOSTON MA 02116 (617) 482-2333 X122
FLUOROPHARMA MEDICAL, INC. (Issuer) CIK: 0001402785 (see all company filings)

IRS No.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 500 BOYLSTON STREET, SUITE 1600 BOSTON MA 02116
Business Address
Spoor Johan M. (Reporting) CIK: 0001535289 (see all company filings)

Type: 4 | Act: 34 | File No.: 333-147193 | Film No.: 111220220